Great growth in underlying revenue and earnings for ccv, very positive imo but seems the market has concentrated on the big drop of reported earnings not quite understanding that this is due to the accounting treatment to the bottom line of the price paid for the termination of the Kentsleigh/Cliffview agency agreement. Even though the transaction will be strongly earnings acretive. I have more than sufficient allocation to this stock and including investment in mny to the sector, otherwise I would use the weakness to top up but dyor.
1st Half Result, page-4
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.8¢ |
Change
-0.003(1.19%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.5¢ | $80.65K | 386.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 195128 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 542448 | 17 |
View Market Depth
| Last trade - 15.45pm 30/07/2024 (20 minute delay) ? |
| CCV (ASX) Chart |